Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Journal of Biomedical Science|October 24, 2017
Accuracy of serum luteinizing hormone and serum testosterone measurements to assess the efficacy of medical castration in prostate cancer patientsJuan Morote, Imma Comas, Roser Ferrer, et al.
European Urology Oncology|March 3, 2021
A Randomised Controlled Trial to Assess the Benefit of Posterior Rhabdosphincter Reconstruction in Early Urinary Continence Recovery after Robot-assisted Radical ProstatectomyAina Salazar, Lucas Regis, Jacques Planas, et al.
European Urology Oncology|August 15, 2019
Who Benefits from Multiparametric Magnetic Resonance Imaging After Suspicion of Prostate Cancer?Juan Morote, Anna Celma, Sarai Roche, et al.
International Journal of Molecular Sciences|August 8, 2014
Role of serum cholesterol and statin use in the risk of prostate cancer detection and tumor aggressivenessJuan Morote, Anna Celma, Jacques Planas, et al.
Urologic Oncology|February 19, 2020
Prostatic-specific antigen density behavior according to multiparametric magnetic resonance imaging resultJuan Morote, Anna Celma, Fernando Diaz, et al.
The World Journal of Men'S Health|January 12, 2022
The Efficacy of Proclarix to Select Appropriate Candidates for Magnetic Resonance Imaging and Derived Prostate Biopsies in Men with Suspected Prostate CancerJuan Morote, Miriam Campistol, Anna Celma, et al.
The International Journal of Biological Markers|February 24, 2022
Who with suspected prostate cancer can benefit from Proclarix after multiparametric magnetic resonance imaging?Juan Morote, Miriam Campistol, Lucas Regis, et al.
European Urology Open Science|March 4, 2022
Improving the Early Detection of Clinically Significant Prostate Cancer in Men in the Challenging Prostate Imaging-Reporting and Data System 3 CategoryJuan Morote, Miriam Campistol, Marina Triquell, et al.
BJU International|August 14, 2012
Metabolic syndrome increases the risk of aggressive prostate cancer detectionJuan Morote, Jordi Ropero, Jacques Planas, et al.
BJU International|August 10, 2021
The current recommendation for the management of isolated high-grade prostatic intraepithelial neoplasiaJuan Morote, Iván Schwartzmann, Anna Celma, et al.
Pageof 2